<strike id="fvzf9"><input id="fvzf9"><form id="fvzf9"></form></input></strike>
    <strike id="fvzf9"><blockquote id="fvzf9"></blockquote></strike>
  1. 
    
  2. <label id="fvzf9"><optgroup id="fvzf9"></optgroup></label>

    <span id="fvzf9"><input id="fvzf9"></input></span>

  3. 掃碼關(guān)注公眾號           掃碼咨詢(xún)技術(shù)支持           掃碼咨詢(xún)技術(shù)服務(wù)
      
    客服熱線(xiàn):400-901-9800  客服QQ:4009019800  技術(shù)答疑  技術(shù)支持  質(zhì)量反饋  關(guān)于我們  聯(lián)系我們
    中文字幕日本αv一区二区_產(chǎn)品中心-北京博奧森生物技術(shù)有限公司
    Recombinant SARS-Cov-2 Spike S1 protein (N501Y, K417N, E484K), His (HEK293) (bs-46017P)  
    訂購熱線(xiàn):400-901-9800
    訂購郵箱:sales@bioss.com.cn
    訂購QQ:  400-901-9800
    技術(shù)支持:techsupport@bioss.com.cn
    100ug/3980.00元
    500ug/12500.00元
    1mg/38000.00元
    大包裝/詢(xún)價(jià)
    產(chǎn)品編號 bs-46017P
    英文名稱(chēng) Recombinant SARS-Cov-2 Spike S1 protein (N501Y, K417N, E484K), His (HEK293)
    中文名稱(chēng) 重組SARS冠狀病毒2 Spike突變蛋白S1(N501Y, K417N, E484K) His tag
    別    名 SARS-CoV-2 spike protein; 2019-nCOV Spike protein; Spike glycoprotein; Spike protein ; Surface glycoprotein; SPIKE_SARS2; 2019-nCOV Spike protein S1(N501Y, K417N, E484K), Recombinant (His Tag); Recombinant SARS-COV-2 Spike S1 (N501Y, K417N, E484K) . ;Recombinant SARS-Cov-2 Spike S1 protein (N501Y, K417N, E484K), His (HEK293)  突變型新冠蛋白; 新冠病毒S蛋白突變體(N501Y, K417N, E484K); 重組新冠病毒 Spike突變蛋白S(N501Y, K417N, E484K); 新型冠狀病毒Spike突變體蛋白;
    克 隆 號
    理論分子量 73 kDa
    檢測分子量 120-140
    性    狀 Lyophilized or Liquid
    濃    度 >0.5 mg/ml
    物    種 SARS-Cov-2
    序    列 16-685/1273
    純    度 >95% as determined by SDS-PAGE
    純化方法 AC
    內毒素 Not analyzed
    表達系統 HEK293 cell
    活性 Yes
    標簽 His
    緩 沖 液 Lyophilized from 0.22um filtered solution in 2X PBS (pH7.4). Normally 5% trehalose is added as protectant before lyophilization.
    保存條件 Stored at -70℃ or -20℃. Avoid repeated freeze/thaw cycles.
    注意事項 This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
    產(chǎn)品介紹 SARS-CoV-2 exploits angiotensin-converting enzyme 2 (ACE2) as a receptor to invade cells. It has been reported that the UK and South African strains may have higher transmission capabilities, eventually in part due to amino acid substitutions on the SARS-CoV-2 Spike protein.The results of a study show the N501Y replacement in this region of the interface (present in both the UK and South African strains) should be favorable for the interaction with ACE2, while the K417N and E484K substitutions (South African strain) would seem neutral or even unfavorable.

    版權所有 2004-2026 radiasunchina.com 北京博奧森生物技術(shù)有限公司
    通過(guò)國際質(zhì)量管理體系ISO 9001:2015 GB/T 19001-2016    證書(shū)編號: 00124Q34771R2M/1100
    通過(guò)國際醫療器械-質(zhì)量管理體系ISO 13485:2016 GB/T 42061-2022    證書(shū)編號: CQC24QY10047R0M/1100
    京ICP備05066980號-1         京公網(wǎng)安備110107000727號
    国产剧情演绎系列丝袜高跟|一级毛片av性爱黄色网站|欧美三级午夜理伦三级|国产av巨作情欲放纵|亚洲 欧美 中文 日韩aⅴ
    <strike id="fvzf9"><input id="fvzf9"><form id="fvzf9"></form></input></strike>
      <strike id="fvzf9"><blockquote id="fvzf9"></blockquote></strike>
    1. 
      
    2. <label id="fvzf9"><optgroup id="fvzf9"></optgroup></label>

      <span id="fvzf9"><input id="fvzf9"></input></span>